Extreme creatine phosphokinase elevation in a 20-year-old man participating in a clinical trial of major depressive disorder.
Shiovitz
Thomas M
TM
Song
Joo Lee
JL
Manlosa
N Bailey
NB
Seliverstov
Maria I
MI
Sharma
Salila
S
D000081:Acetamides / Q000627:therapeutic use; D000328:Adult; D003402:Creatine Kinase / Q000097:blood*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D003951:Diagnostic Errors; D019587:Dietary Supplements / Q000009:adverse effects*; D016903:Drug Monitoring; D015444:Exercise; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis*; D016032:Randomized Controlled Trials as Topic; D009281:Naphthalenes
D000081:Acetamides; D003402:Creatine Kinase; D006993:Hypnotics and Sedatives; C084711:agomelatine; D009281:Naphthalenes